Physician profile
Ryosuke Misawa
NPI 1124387907
$2,185.06
in general payments reported to CMS, 2019-2025
16 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $92.82 · 2023: $453 · 2024: $872 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,092.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $425.01 | 2023-2024 | Signia |
| Dilon Technologies, INC. | $414.82 | 2023-2025 | Hemoblast Bellows |
| Davol INC. | $335.73 | 2024 | Phasix Mesh |
| Becton, Dickinson and Company | $170.61 | 2025 | Arista |
| Ethicon US, LLC | $147.55 | 2025 | Echelon Flex |
| W. L. Gore & Associates, INC. | $141.56 | 2024-2025 | Gore Tag Conformable Thoracic Stent Graft, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Werfen USA LLC | $124.55 | 2023 | |
| Astrazeneca Pharmaceuticals Lp | $118.00 | 2023 | Imfinzi |
| Gilead Sciences, INC. | $92.82 | 2022 | |
| Organox Ltd | $64.45 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $32.39 | 2025 | Iqirvo |
| Veloxis Pharmaceuticals, INC. | $30.63 | 2025 | Envarsus |
| Orphalan INC | $30.07 | 2024 | Cuvrior |
| Melinta Therapeutics, LLC | $22.13 | 2023 | Vabomere, Rezzayo, Orbactiv |
| Intercept Pharmaceuticals, INC. | $17.64 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.10 | 2025 | Prevymis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryosuke Misawa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.